EDAPT Glucose Regulation Practice Test

The best response regarding the use of repaglinide in relation to hypoglycemia is to clarify that this medication should be taken before meals. Repaglinide is an oral medication that stimulates the pancreas to release insulin, helping to lower blood glucose levels. Taking it before meals allows the medication to start working as glucose enters the bloodstream during the meal, which is essential for effective blood sugar management. When clients express concerns about hypoglycemia, it’s important to address the timing of their medication. Taking repaglinide before eating can help minimize the risk of hypoglycemia because it aligns the medication's peak action with the rise in blood glucose levels from the meal they are about to consume. This strategic timing helps prevent the blood glucose from dropping too low, a common concern for users of fast-acting medications like repaglinide. The other options present misunderstandings about the timing and usage of repaglinide. Switching to a faster-acting insulin may not be necessary and could complicate a client's management plan. Advising to take the medication in the morning only overlooks its need to be taken in relation to meals, while stating it must be taken only after meals contradicts the fundamental usage instructions for this medication. Proper education and reassurance